StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen total Contractual Debt Principal Maturities ($M) ($M)

Form 10-K Financing Arrangements Note (XBRL)

Latest, FY2025
56,044
Period ended Dec 31, 2025
Change on a year earlier
-9.3%
61,778 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Contractual Debt Principal Maturities ($M) ($M)Year on yearSource
FY2025Dec 31, 202556,044-9.3%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202461,778-6.9%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202366,347+63.3%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 202240,628+18.7%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 202134,238+1.9%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 202033,608+10.3%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 201930,475-12.6%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 201834,878-3.8%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 201736,271+2.1%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 201635,532+12.3%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 201531,640–Form 10-K (filed 2016-02-16) ↗

Breakdown

What makes up total contractual debt principal maturities ($m)

Cite this data

StockData. (2026). Amgen Total Contractual Debt Principal Maturities ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/debt_mat_tot

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.